Suberoylanilide hydroxamic acid suppresses axonal damage and neurological dysfunction after subarachnoid hemorrhage via the HDAC1/HSP70/TDP-43 axis

Kui Luo,Zhifei Wang,Kai Zhuang,Shishan Yuan,Fei Liu,Aihua Liu
DOI: https://doi.org/10.1038/s12276-022-00761-9
2022-05-03
Abstract:Experimental & Molecular Medicine, Published online: 02 May 2022; doi:10.1038/s12276-022-00761-9 Analysis of the molecular processes involved in the progression of hemorrhage-induced brain damage has yielded a potential therapeutic target. Fei Liu and Aihua Liu at the Central South University in Changsha, China, and co-workers examined mechanisms behind the extensive brain damage that can be caused by subarachnoid hemorrhage, bleeding in a space between the brain and its surrounding membranes. In experiments on human samples and rat models, the researchers showed that the TDP-43 protein was over-expressed in cerebrospinal fluid after hemorrhage, and that the build-up of this protein aggravated nerve cell damage and dysfunction. TDP-43 is regulated by a pathway involving a potent enzyme involved in regulation of gene expression called HDAC1. Treatment of rat models with an HDAC1 inhibitor degraded TDP-43 and limited the progression of brain damage.
biochemistry & molecular biology,medicine, research & experimental
What problem does this paper attempt to address?